We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi, BMS’ Plavix Wins Six Months of Protection From Generics
Sanofi, BMS’ Plavix Wins Six Months of Protection From Generics
February 2, 2011
The FDA has granted Sanofi-Aventis and Bristol-Myers Squibb (BMS) six months of pediatric exclusivity on their blockbuster blood-thinner Plavix.